A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
Jiangdian Song(China Medical University), Jie Tian(Shanghai Jiao Tong University), Bojiang Chen(Sichuan University), Wen‐Zhao Zhong(Guangdong Academy of Medical Sciences), Yue Cheng, Kun Wang(Chinese Academy of Sciences), Weimin Li(Sichuan University), Changhong Liang(Guangdong Academy of Medical Sciences), Di Dong(Chinese Academy of Sciences), Ping Zhou(Capital Medical University), Ning Wu(Regeneron (United States)), Yanqi Huang(Southern Medical University), Yongzhao Zhou(Sichuan University), Mengjie Fang(Chinese Academy of Sciences), Zhenyu Liu(Shanxi Agricultural University), Yuncui Gan(Sichuan University), Zaiyi Liu(Key Laboratory of Guangdong Province), Jingyun Shi(Tongji University)
Cited by 198
Related Papers
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
|Theranostics|2019|1k
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
|JAMA Oncology|2023|822
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
|Clinical Cancer Research|2017|562
Central focused convolutional neural networks: Developing a data-driven model for lung nodule segmentation
|Medical Image Analysis|2017|489
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
|European Respiratory Journal|2019|441